You are here: Home » PTI Stories » National » News
Business Standard

Novel immunotherapy may treat egg allergy

Health Medical Pharma

Press Trust of India  |  Washington 

An oral immunotherapy can treat egg allergy, allowing patients to safely incorporate the highly nutritious food into their diet, scientists say.

For a study, participants completed up to four years of egg oral immunotherapy (eOIT) treatment.

According to researchers from University of North Carolina (UNC) in the US, certain participants were able to safely incorporate egg into their diet for five years.

"Egg allergy is one of the most common food allergies and usually appears in early childhood. It has significant risk for severe allergic reactions and negatively affects quality of life for children with the allergy," said Edwin Kim, assistant professor at the UNC.

"While the allergy does seem to go away with age, it can last into the second decade of life for most people. Any treatment that can allow the introduction of egg into the diet of someone with egg allergy provides nutritional benefits and peace of mind for the patient and their family," said Kim.

The trial began with either eOIT or a placebo for 55 patients aged 5-11 who were allergic to egg. The treatments were randomised -- 40 participants received eOIT and 15 received the placebo.

The treatments lasted up to four years, during which patients were tested for their sensitivity to egg.

Those who were considered desensitised --requiring a higher quantity of egg to cause an allergic reaction -- could eat 10 grams, or about two teaspoons, of pure egg without reaction.

Desensitised patients then stopped eOIT and were tested for sensitivity again. Those who did not have a reaction were considered sustained unresponsiveness (SU).

After completing eOIT, concentrated egg (scrambled, fried or boiled egg) and/or baked egg (eggs incorporated into something like a cake) were recommended to be added into the patients' diet.

For five years following the allergy treatment, patients were asked to report how much egg they ate, in what form they ate it, how often they ate it and how they felt afterward.

At the end of eOIT, 50 per cent of patients were classified with SU, 28 per cent of patients were classified as desensitised (without SU) and 22 percent as not desensitised.

Of SU-classified patients, all were able to eat both baked and concentrated egg.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, February 24 2019. 17:25 IST